Glioblastoma Clinical Trials in Kansas City, MO

Glioblastoma Clinical Trials in Kansas City, MO

View the best 10 glioblastoma medical studies in Kansas City, Missouri. Access promising new therapies by applying to a Kansas City-based Glioblastoma clinical trial.

Trials in Kansas City, Missouri

Here are the top 9 medical studies for glioblastoma in Kansas City, Missouri

Image of University of Arizona in Tucson, United States.

NanO2TM

Oxygen Enhancer

Recruiting0 awardsPhase 2
This trial is testing a new treatment that delivers more oxygen to tumors. It aims to help patients with a specific type of brain cancer by making radiation therapy more effective. By increasing oxygen levels in the tumor, the treatment helps radiation work better at killing cancer cells.
Image of Centralia Oncology Clinic in Centralia, United States.

Lomustine +2 More

Alkylating agents

Recruiting2 awardsPhase 3
This trial is comparing the effect of adding lomustine to temozolomide and radiation therapy versus temozolomide and radiation therapy alone in treating newly diagnosed MGMT methylated glioblastoma.
Image of Children's Hospital of Alabama in Birmingham, United States.

Temozolomide +2 More

Alkylating Agent

Recruiting1 awardPhase 2
This trial is studying a combination of drugs as a potential treatment for newly diagnosed malignant glioma. The drugs being studied are veliparib, radiation therapy, and temozolomide.
Image of Duke University in Durham, United States.

Atezolizumab

Checkpoint Inhibitor

Recruiting1 awardPhase 2
"This trial aims to see if giving atezolizumab before surgery can help patients with recurrent glioblastoma and low mutational burden."
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Temozolomide +2 More

Alkylating agents

Recruiting1 awardPhase 2
This trial is studying how well two types of radiation therapy work compared to standard radiation therapy when given with temozolomide in patients with newly diagnosed glioblastoma.
Image of Banner MD Anderson in Gilbert, United States.

APL-101

Small Molecule Inhibitor

Recruiting1 awardPhase 2
This trial is testing APL-101, a new drug, on patients with specific genetic changes in their cancer. These patients often don't respond to typical treatments. The drug aims to block a protein that helps cancer cells grow and spread.
Image of University of Kansas Medical Center in Olathe, United States.

Radiotherapy +2 More

Radiation

Recruiting1 awardPhase 2 & 3
This trial will study an immunotherapy combining a cancer-patient's own cells and standard treatment to fight glioblastoma. Immune cells will be harvested from the patient, stimulated and expanded, then infused back.
Image of Vidant Health in Greenville, United States.

GammaTile radiation therapy implantation +3 More

Brachytherapy

Recruiting3 awardsPhase 4
This trial tests if adding GammaTile radiation therapy to standard treatment can improve outcomes for patients with newly diagnosed GBM. GammaTile delivers quick, direct radiation to the tumor, which may help control the tumor better and improve survival rates.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Temozolomide

Alkylating agents

Recruiting0 awardsPhase 2 & 3
This trial is studying the combination of temozolomide and veliparib compared to temozolomide alone in treating patients with newly diagnosed glioblastoma multiforme.

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.